[IMRX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[IMRX] Immuneering Corporation
Announcement Date
29-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -22.06%
YoY-
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 482 660 748 665 683 481 483 -0.13%
PBT -8,534 -7,987 -6,230 -5,836 -4,399 -3,604 -3,201 92.15%
Tax -17 1 0 42 -0 1 0 -
NP -8,534 -7,988 -6,230 -5,836 -4,399 -3,604 -3,201 92.15%
Tax Rate - - - - - - - -
Total Cost 9,016 8,648 6,978 6,501 5,082 4,085 3,684 81.50%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -1,770.08 -1,210.18 -832.62 -877.48 -644.49 -749.56 -662.61 92.41%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.47 -0.33 -0.46 -0.43 -0.33 -0.27 -0.24 56.46%
EPS Diluted -0.47 -0.33 -0.46 -0.43 -0.33 -0.27 -0.24 56.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.